Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

ClinicalTrials.gov ID: NCT00118742

Public ClinicalTrials.gov record NCT00118742. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-label Study of the Effect of a Long-term Calcineurin Inhibitor-free Maintenance Regimen With CellCept and Sirolimus on Preservation of Renal Function and Prevention of Acute Rejection in Recipients of an Orthotropic Liver Transplant

Study identification

NCT ID
NCT00118742
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
293 participants

Conditions and interventions

Interventions

  • mycophenolate mofetil [CellCept] Drug
  • Tacrolimus Drug
  • Cyclosporine Drug
  • Sirolimus Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 74 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2005
Primary completion
Jun 30, 2008
Completion
Nov 30, 2008
Last update posted
Aug 2, 2010

2005 – 2008

United States locations

U.S. sites
41
U.S. states
24
U.S. cities
34
Facility City State ZIP Site status
Not listed Birmingham Alabama 35294
Not listed Phoenix Arizona 85054
Not listed La Jolla California 92037
Not listed Los Angeles California 90033-4612
Not listed Los Angeles California 90095
Not listed San Diego California 92103-8401
Not listed San Francisco California 94115
Not listed San Francisco California 94143-0780
Not listed Denver Colorado 80262
Not listed Jacksonville Florida 32216
Not listed Miami Florida 33136
Not listed Tampa Florida 33606
Not listed Atlanta Georgia 30322
Not listed Chicago Illinois 60611
Not listed Chicago Illinois 60612-3824
Not listed New Orleans Louisiana 70121
Not listed Baltimore Maryland 21201
Not listed Boston Massachusetts 02111
Not listed Boston Massachusetts 02114-2696
Not listed Boston Massachusetts 02215
Not listed Burlington Massachusetts 01805
Not listed Detroit Michigan 48202-2689
Not listed Minneapolis Minnesota 55455
Not listed Rochester Minnesota 55905
Not listed St Louis Missouri 63110
Not listed Newark New Jersey 07101-1709
Not listed Hawthorne New York 10532
Not listed New York New York 10016
Not listed New York New York 10029
Not listed New York New York 10032
Not listed Chapel Hill North Carolina 27599
Not listed Cleveland Ohio 44195
Not listed Oklahoma City Oklahoma 73112-4481
Not listed Portland Oregon 97201-3098
Not listed Philadelphia Pennsylvania 19141
Not listed Nashville Tennessee 37232
Not listed Dallas Texas 75246
Not listed Houston Texas 77030
Not listed San Antonio Texas 78284
Not listed Richmond Virginia 23298
Not listed Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00118742, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 2, 2010 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00118742 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →